27 batches of Doliprane 2.4% oral suspension, for babies and children, are being recalled by the French Agency for the Safety of Medicines. The reason for this is a defect in the pipette supplied with it, and the risk it poses to the dosage.
Doliprane Recall for Children: beware of this defect on the pipettes, here are the batches to bring back in
